FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/05/019249 [Registered on: 21/05/2019] Trial Registered Prospectively
Last Modified On: 15/07/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To see the effect & safety of “ Edagajadi yoga &Gandhapashanadilepa” in the skin disease (ptyriasis versicolor) sidhma 
Scientific Title of Study   A RANDOMISED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY& SAFETY OF “EDAGAJADIYOGA & GANDHAPASHANADI LEPA” IN THE MANAGEMENT OF SIDHMA KUSHTHA W.S.R TO PITYRIASIS VERSICOLOR  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrHarishBhakuni 
Designation  Assistant proffessor 
Affiliation  NATIONAL INSTITUTE OF AYURVEDA  
Address  PG DEPARTMENT OF KAYACHIKITSA NATIONAL INSTITUTE OF AYURVEDA JORAWAR SINGH GATE,AMER ROAD JAIPUR RAJASTHAN 302002

Jaipur
RAJASTHAN
302002
India 
Phone  7976128396  
Fax    
Email  harishbhakuni78@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrHarishBhakuni 
Designation  Assistant proffessor 
Affiliation  NATIONAL INSTITUTE OF AYURVEDA  
Address  PG DEPARTMENT OF KAYACHIKITSA NATIONAL INSTITUTE OF AYURVEDA JORAWAR SINGH GATE,AMER ROAD JAIPUR RAJASTHAN 302002

Jaipur
RAJASTHAN
302002
India 
Phone  7976128396  
Fax    
Email  harishbhakuni78@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrRadhikasPukale 
Designation  PG Scholar 
Affiliation  NATIONAL INSTITUTEOF AYURVEDA 
Address  PG DEPARTMENT OF KAYACHIKITSA NATIONAL INSTITUTE OF AYURVEDA JORAWAR SINGH GATE AMER ROAD JAIPUR RAJASTHAN 302002

Jaipur
RAJASTHAN
302002
India 
Phone  8618763625  
Fax    
Email  radhika.s.pukale@gmail.com  
 
Source of Monetary or Material Support  
NATIONAL INSTITUTE OF AYURVEDA JORAWAR SINGH GATE AMER ROAD JAIPUR 302002 
 
Primary Sponsor  
Name  NATIONAL INSTITUTE OF AYURVEDA  
Address  NATIONAL INSTITUTE OF AYURVEDA JORAWAR SINGH GATE,MAER ROAD JAIPUR RAJASTHAN 302002  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrRADHIKA S PUKALE   National Institute of Ayurveda & Hospital  OPD 1,7,25,18 PG Department of Kayachiktsa
Jaipur
RAJASTHAN 
8618763625

radhika.s.pukale@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L448||Other specified papulosquamous disorders,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  EDAGAJADI LEPA GANDHAPASHANADI LEPA   Registered patient of Sidhma kushtha (pityriasis versicolor) will be administered Edagajadi yoga orally in the dose of 40ml before meals two times in a day for 35days with external application of Gandhapashanadi lepa twice in a day for 35 days, on the lesion(as per needed)  
Comparator Agent  KETACANAZOLE 2% OINTMENT TAB. FLUCANAZOLE 150mg  Registered patient of Sidhma kushtha (pityriasis versicolor) will be given ketoconazole 2% ointment for local application every night for 35 days, along with oral Tab. Fluconazole 150mg weekly once for 5weeks.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients willing for trial.
2. The patients in the age group of 18– 60 years.
3. The patients having clinical signs and symptoms of Sidhmakushtha & Pityriasis versicolor.
4. Patient with positive KOH test for Pityriasis versicolor
5. The patients with duration of symptoms less than 5 year duration
 
 
ExclusionCriteria 
Details  1. Patients below the age of 18years and above 60years.
2. Patients with duration of illness >5 years.
3. Patients with long term history of steroid and cytotoxic treatment.
4. Patients having concomitant illness like HTN, DM-II etc.
5. Patients with evidence of malignancy.
7. Pregnant or lactating women.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Change in the clinical symptoms of Sidhmakushtha (pityriasisversicolor).
1) Size
2) Color/pigmentation
3) Number of Lesions.
4) Site of Lesion/area of involvement
5) Itching
 
35DAYS
 
 
Secondary Outcome  
Outcome  TimePoints 
Change in the objective parameters  35DAYS 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "50"
Final Enrollment numbers achieved (India)="50" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   03/06/2019 
Date of Study Completion (India) 25/03/2020 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   none 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  

Pityriasis versicolor is well defined skin disorder with multiple asymptomatic mild itchy macular/ papular lesions with fine branny powdery scales having hypo or hyper pigmented macules (versi several). Initially the lesion occurs around the hair follicles but soon merges with each other to form large area which persists indefinitely and shows spontaneous remission and exacerbation. 

 Ayurveda has a great potential in managing this condition along with overcoming the side effects of antifungals like stinging and swelling, irritation or redness of the treated skin and the time duration for the drug application is limited because it causes the toxicity which does not fulfill the need of treatment. Many a times, it so happens that even after treatment the hypo-pigmentation persists months after treatment and causes mental instability or social stigma to the patient. The toxic effects of topical mode of action of antifungals like allergic rashes, scars, itching, oozing, etc, so due to its short comings and after reviewing the Ayurvedic classics, drugs effective in conditions similar to Sidhma Kushta and pityriasis versicolor were selected .the references of the drug which has kushthagna properties, along with tikta, madhur, katu rasa pradhana dravyas were selected

1. To evaluate the efficacy of â€˜Edagajadi yoga’ & “Gandhapashanadilepa’ in the management of Sidhma kushtha (pityriasis versicolor).

2. Clinical evaluation of safety of â€˜Edagajadi yoga &Gandhapashanadilepa in the management of   Sidhma kushtha (pityriasis versicolor).

3. To evaluate comparative efficacy of Edagajadi yoga &Gandhapashanadilepa in the management conditions similar to Sidhmakushtha & pityriasis versicolor with a controlled group of allopathic antifungal line of treatment. 

Study type: Interventional Randomized controlled trial

Purpose: To assess the Efficacy of the trial drug

Masking: Open label

Timing:  Prospective

Endpoint: Efficacy and safety

No. of group:  Two                       

Number of patients completed in the clinical trial: 50

Duration: 35 days

Summary is the short review of whole thesis work which gives us the idea about what was the project, how it was conducted & what end results we had got ultimately. Ayurveda, though ancient but still contemporary and potential enough to dealing the diseases of present era. This system of medicine has its own modes of handling a pathological condition where by the consequences are absolutely desirable. The current research work entitled as A Randomized   controlled clinical   study to evaluate the efficacy and safety of Edagajadi yoga and Gandhapashanadi lepa in the management of Sidhmakushta w.s.r to pityriasis versicolor was carried out with following aims and objectives.Present Research work has been undertaken with the following objectives

The current project has been presented in five parts:

 Conceptual study (Ayurvedic review, Modern review)

Drug review

Clinical study

Discussion

Summary & Conclusion

Conceptual study: - It is further divided into following parts-.

Ayurvedic review: - In disease review, detailed description regarding etymological derivation, Nidana (causative factors), Purvaroopa, Roopa (signs and   symptoms) and   Samprapti (pathogenesis), Sadhyasadhyata, Chikitsa of the disease Sidhma, as per Ayurvedic view is done with possible correlation of Sidhma and Pityriaisis versicolor wherever applicable.

Modern review:-The section deals regarding Pityriaisis versicolor in regard to its etymology, definition, epidemiology, classification by various types, etiology, triggering factors, signs & symptoms, diagnosis, investigations, differential diagnosis, complications, prevention and management.

Drug review:-In Drug Review, the detail about the trial drugs â€˜Edagajadi yoga’ and â€˜Gandhapashanadi lepa’ from the reason of their selection and preparation of the yoga described. Constituent of trial drugs was explained in detail along with Ayurvedic properties, chemical constituents, pharmacological activity & related research works.

Edagajadi yoga contain drug- Cakramrada, Kushtha, Aragwadha, Haridra , Daruharidra, Pippali which are collectively of  Kaphavatahara property  and directly acts on the causative doshas. The drug also has a potential property of alleviating both Kapha and Vata by Katu- Tikta rasa and ushna veerya. Thus Kaphavatashamaka properties of drug help in clearing the srotorodha and digestion of Ama, which helps in facilitating jathara-agni and dhatvagni restoring normal functions of skin. The combination of above mentioned drugs are KushthaghnaKandughnaRaktashodhakaVarnya ,Twagdoshahara, Krimighna, Balya and Rasayana properties, which clearly explain its mode of action in Sidhma.

Gandhapashanadi Lepa contain drugs:  Gandhak, Yavkshara, Sarshapa tail. Upon topical application, the active principle of the Tail reaches to the deeper tissues through Siramukha & Swedavahi srotas by virtue of its effect it with its Sukshma & Tikshna property. Due to its Ushna, Laghu, Ruksha properties it removes the obstruction in Swedavahi srotas and allows the local toxins to flow out through the Sweda, thus clearing out the micro channels. In most of the patients Kandu was relieved significantly due to Kusthaghna and Kandughna properties of Yavkshara & Gandhak.

In modern terms, the individual ingredients have anti-inflammatory, anti-fungal, hepato-protective, antibacterial, melanin regulation and blood purifier properties. A probable mode of action of the drug was assumed based on the classical analysis of Rasa panchaka and Dosha-vyadhi karma along with modern pharmacology of individual drugs.

Fluconazole Fluconazole is a triazole antifungal, inhibiting cytochrome P450-dependent ergosterol. Reduced dosage is recommended in patients with chronic hepatic or renal disease. There are no significant adverse drug interactions and there is no significant cardiotoxicity.

Ketoconazole ointment Ketoconazole, an imidazole, is a broad-spectrum antifungal used in the treatment of superficial and systemic mycoses. Through inhibition of the enzyme lanosterol 14-α-demethylase, ketoconazole disrupts ergosterol biosynthesis to limit cell function and growth.

Clinical Study:

This section contains aims & objectives, material & methods, criteria for selection of patients, criteria for diagnosis, laboratory investigations, plan of treatment, criteria for assessment, vital data of the observations of all the patients and the results obtained from the present clinical study along with their statistical analysis Wilcoxon matched-pairs signed ranks Test and Paired ‘t’ Test for intra group subjective and objective parameters and Mann-whitney Test, Unpaired ‘t’ Test for inter group comparison of subjective and objective parameters,  according to type of data.

The patients of Sidhma (Pityriasis Versicolor) were randomly selected for the present study, from the Kayachikitsa OPD and IPD of NIA Jaipur.

50 clinically diagnosed and registered patients of Sidhma were divided randomly into 2 groups. Each group have 25 patients.

GROUP A- Treated with Edagajadi yoga  (10 gms) ) with kwatha , before meal two times in a day for 30 days and Gandhapashanadi Lepa twice in a day for 30 days, on the lesion of Pityriasis Versicolor.

GROUP B- Treated with Fluconazole tab. (oral 150mg / week) and Ketoconazole ointment twice daily for 30 days, on the lesion of Pityriasis Versicolor.

Dietary /life style restrictions:The patients were strictly advised to follow the restrictions regarding food, food habits and life style. The aim was to avoid the etiological factors. 

Observation & Results:-The demographic data and clinical observations tabulated. Effect on Ayurvedic and modern symptoms is described in the form of % improvement. The obtained results and its analysis have been given in the form of tables and graphs. The demographic data and clinical observations were tabulated.

In the present study maximum 48% patients were in age group  16-26 years, 50 % of the patients were female & male, 78% patients from Hindu community, 52% were unmarried, maximum number of patients (28%) were found having graduate educational status, maximum patients 60 % were discovered to be of middle socio-economic status, maximum number of patients (48%) were students, maximum number of  patients i.e (52%) were having this disease with a chronicity of 1-3 years, maximum number of patients (72%) had gradual onset, maximum number of patients (99%) suffered more itching in lesion in summer, maximum number of patients (88%) in this study were having shweta varna (hypopigmented lesions) type of Sidhma, maximum number of patients (25.27%) had lesions on chest, maximum 64% patients were mixed type of diet, maximum number of patients (58%)  were having disturbed sleep.

In the present study the data reveals that maximum 52% patients were having Vatakaphaja prakriti, maximum number of patients (78%) were of madhyama sara, 72% were of madhyama samhanana and 68% patients were of madhyama pramana, maximum number of patients (66%) from madhyama satmya, maximum number of the patients (68%) were having madhyama satva, 78% patients were having madhyama ahara shakti, 66% were having madhyama jarana shakti, 62% patients were having madhyama vyayama shakti.

Results in the patients of Group A:In Group A, patients were treated with  Edagajadi yoga (kwath) in a dose of 10gm  two times in a day before meal and Gandhapashanadi lepa for local application twice in a day, showed highly significant results (p value :  P < 0.01,  P < 0.001, P<0.0001) in following subjective parameters; Kandu, Mandala, Size of lesion, Vaivarnyata, Raji, Area of involvement, Hamilton depression scale with percentage relief of 38%, 33%, 28.6%, 15.6%, 57.3%, 19%, 75.81% respectively.

Objective parameters- TLC, Serum creatinine showed highly significant result with giving (percentage of decrease) an improvement of 20.31%, 13.04%. SGOT, SGPT, Hb %, Eosinophil, KOH Mount shown significant result of 8.33%, 10.07%, 2.49%, 11.64%,16% respectively. ESR, RBS, Blood Urea have shown no significant result.

Results in the patients of Group B:In Group B, highly significant results (p value:  P < 0.01, P < 0.001, P<0.0001) obtained in subjective parameters like; Kandu, Mandala, Size of lesion, Vaivarnyata, Raji, Hamilton depression scale with percentage relief of 18%,20%, 22.6%, 9.88%, 36%%, 43.9% respectively. Area of involvement showed significant result (p value <0.05) with percentage relief of 4.67%.

Discussion:-In Discussion, the entire outcome of research was critically analyzed for logical explanation and evaluation of the evidences base on the effect of the test drugs on the selected disease.Under this heading, the total studies in concise along with the results obtained after administration of regimen is stated. The probable mode of action of the Shamana therapy â€˜Edagajadi yoga’ and ‘Gandhapashanadi lepa’ as a whole in the management of Sidhma is discussed.

The main logic behind the actions is:

The ushna veerya has kaphavatahara properties neutralize the doshika pathogenesis.

Deepana-pachana karma- neutralize ama

Rasayana, jivaniya, balya properties improve Vyadhikshamatwam to fight against disease.

The Dosha-prashamana effect acts on the main doshas which contribute to the Samprapti viz.  Kapha and Vata.

 The Vyadhi prashamana effect acts on the main vyadhi by Kushthaghna, Kandughana prabhava of the drugs.

In contemporary parlance, the anti-inflammatory, hepato-protective, blood purifier activity, a probable anti-fungal and antibacterial activity respond the result of cardinal symptoms.

 

 
Close